Mar 19 |
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency
|
Mar 15 |
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Annual Results: Here's What Analysts Are Forecasting For This Year
|
Mar 14 |
ClearPoint Neuro Full Year 2023 Earnings: Beats Expectations
|
Mar 13 |
ClearPoint Neuro, Inc. (CLPT) Q4 2023 Earnings Call Transcript
|
Mar 12 |
ClearPoint Neuro Inc Reports Robust Revenue Growth in Q4 and Full-Year 2023
|
Mar 12 |
ClearPoint Neuro reports Q4 results
|
Mar 12 |
ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results
|
Mar 11 |
ClearPoint Neuro Q4 2023 Earnings Preview
|
Mar 11 |
Earnings Outlook For ClearPoint Neuro
|
Mar 11 |
Journal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism® Neuro Laser Therapy System
|